Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

NCT03301350 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Triple Negative Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Pegfilgrastim
DRUG: Filgrastim

Sponsor

University of Wisconsin, Madison